Logo

American Heart Association

  103
  0


Final ID:

TTR Amyloidosis: Not so rare in vulnerable populations

  • Goyal, Parag  ( Weill Cornell Medicine , New York , New York , United States )
  • Argiro, Alessia  ( Careggi University Hospital , Florence , Italy )
  • Arora, Pankaj  ( UNIVERSITY OF ALABAMA AT BIRMINGHAM , Birmingham , Alabama , United States )
  • Author Disclosures:
    Parag Goyal: DO have relevant financial relationships ; Consultant:Axon therapies:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:Bridgebio:Active (exists now) ; Consultant:Bayer HealthCare:Active (exists now) | Alessia Argiro: DO NOT have relevant financial relationships | Pankaj Arora: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:
More abstracts on this topic:
Measuring and shifting the social determinants of health in genetic heart disease

Li Jennifer, Khan Sadiya, Day Sharlene, Sanchez Eduardo

Bridging the Gap: The Impact of Underrepresentation in Population Biobanks

Clarke Shoa, Bick Alexander, Tcheandjieu Catherine

More abstracts from these authors:
Association of the AHA’s PREVENT-HF score with Incident Heart Failure Subtypes in the REGARDS study.

Nordberg Megan, Cherrington Andrea, Arora Pankaj, Safford Monika, Goyal Parag, Levitan Emily, Muntner Paul, Khodneva Yulia

Targeting Cardiac Amyloidosis with siRNA: A New Era in Therapeutic Intervention

Arora Pankaj

You have to be authorized to contact abstract author. Please, Login
Not Available